PMC9205741_01
Esophagogastroduodenoscopy of the gastric mucosa reveals a suspected mass in the gastric mucosa, as highlighted by arrows, along with areas of inflammation. Imaging is limited by bile reflux. Image Credit: Michael Sciarra.
CRIGM2022-5143760.001.jpg
PMC9205741_01_CRIGM2022-5143760.001.jpg
fig1
Subsequently, esophagogastroduodenoscopy was performed, which revealed a gastric mass with gastritis, as shown in Figure 1 and Figure 2.
Esophagogastroduodenoscopy of gastric mucosa. The gastric body reveals active areas of inflammation. Image Credit: MichaelSciarra.
CRIGM2022-5143760.002.jpg
PMC9205741_01_CRIGM2022-5143760.002.jpg
fig2
Subsequently, esophagogastroduodenoscopy was performed, which revealed a gastric mass with gastritis, as shown in Figure 1 and Figure 2.
Histological evaluation of gastric mucosa. Slide (a): High-grade lymphoma seen under the gastric surface epithelium. Slide (b): Positive reactivity for CD30 with the use immunostaining. Slide (c): Tumor cells found to be positive for Epstein-Barr virus-encoded small RNA (EBER) with in situ hybridization. Image Credit: Kunchang Song.
CRIGM2022-5143760.003.jpg
PMC9205741_01_CRIGM2022-5143760.003.jpg
fig3
A gastric biopsy revealed immunophenotypic features consistent with primary effusion type high-grade Epstein-Barr virus- (EBV-) related CD30+ lymphoma, as shown in Figure 3.